Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CTAC - NL0000345577 - Common Stock

3.02 EUR
-0.01 (-0.33%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CTAC scores 5 out of 10 in our fundamental rating. CTAC was compared to 76 industry peers in the IT Services industry. CTAC has only an average score on both its financial health and profitability. CTAC may be a bit undervalued, certainly considering the very reasonable score on growth CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • In the past year CTAC had a positive cash flow from operations.
  • CTAC had positive earnings in each of the past 5 years.
  • CTAC had a positive operating cash flow in each of the past 5 years.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

  • CTAC has a better Return On Assets (8.07%) than 82.89% of its industry peers.
  • CTAC has a Return On Equity of 18.74%. This is in the better half of the industry: CTAC outperforms 77.63% of its industry peers.
  • CTAC's Return On Invested Capital of 6.80% is in line compared to the rest of the industry. CTAC outperforms 43.42% of its industry peers.
  • CTAC had an Average Return On Invested Capital over the past 3 years of 7.72%. This is significantly below the industry average of 25.87%.
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROIC 6.8%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CTAC has a Profit Margin of 3.10%. This is comparable to the rest of the industry: CTAC outperforms 48.68% of its industry peers.
  • In the last couple of years the Profit Margin of CTAC has grown nicely.
  • CTAC's Operating Margin of 2.97% is on the low side compared to the rest of the industry. CTAC is outperformed by 65.79% of its industry peers.
  • CTAC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CTAC (37.21%) is worse than 67.11% of its industry peers.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
  • The number of shares outstanding for CTAC remains at a similar level compared to 1 year ago.
  • CTAC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CTAC has been reduced compared to a year ago.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.79 indicates that CTAC is not in any danger for bankruptcy at the moment.
  • CTAC has a better Altman-Z score (3.79) than 76.32% of its industry peers.
  • A Debt/Equity ratio of 0.36 indicates that CTAC is not too dependend on debt financing.
  • CTAC has a better Debt to Equity ratio (0.36) than 60.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 3.79
ROIC/WACC1.05
WACC6.46%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a worse Current ratio (1.00) than 65.79% of its industry peers.
  • A Quick Ratio of 1.00 indicates that CTAC may have some problems paying its short term obligations.
  • CTAC has a worse Quick ratio (1.00) than 60.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

  • CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 300.00%, which is quite impressive.
  • Measured over the past years, CTAC shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.53% on average per year.
  • CTAC shows a decrease in Revenue. In the last year, the revenue decreased by -2.28%.
  • CTAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%

3.2 Future

  • Based on estimates for the next years, CTAC will show a very strong growth in Earnings Per Share. The EPS will grow by 21.55% on average per year.
  • Based on estimates for the next years, CTAC will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

  • CTAC is valuated reasonably with a Price/Earnings ratio of 10.79.
  • CTAC's Price/Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 92.11% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, CTAC is valued rather cheaply.
  • A Price/Forward Earnings ratio of 7.05 indicates a rather cheap valuation of CTAC.
  • CTAC's Price/Forward Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 93.42% of the companies in the same industry.
  • CTAC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.31.
Industry RankSector Rank
PE 10.79
Fwd PE 7.05
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 88.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.43
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTAC's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.23
PEG (5Y)0.44
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.64%, CTAC has a reasonable but not impressive dividend return.
  • CTAC's Dividend Yield is a higher than the industry average which is at 2.26.
  • Compared to an average S&P500 Dividend Yield of 1.92, CTAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

  • The dividend of CTAC is nicely growing with an annual growth rate of 17.42%!
Dividend Growth(5Y)17.42%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 26.85% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
  • The dividend of CTAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.85%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (1/15/2026, 7:00:00 PM)

3.02

-0.01 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap42.73M
Revenue(TTM)188.22M
Net Income(TTM)5.81M
Analysts85
Price Target2.97 (-1.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend0.11
Dividend Growth(5Y)17.42%
DP26.85%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.79
Fwd PE 7.05
P/S 0.23
P/FCF N/A
P/OCF 20.74
P/B 1.38
P/tB 8.55
EV/EBITDA 4.43
EPS(TTM)0.28
EY9.27%
EPS(NY)0.43
Fwd EY14.19%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.15
OCFY4.82%
SpS13.23
BVpS2.19
TBVpS0.35
PEG (NY)0.23
PEG (5Y)0.44
Graham Number3.72
Profitability
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROCE 14.63%
ROIC 6.8%
ROICexc 7.19%
ROICexgc 19.37%
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
ROICexc(3y)9.79%
ROICexc(5y)10.06%
ROICexgc(3y)82.95%
ROICexgc(5y)110.67%
ROCE(3y)14.7%
ROCE(5y)14.69%
ROICexgc growth 3Y-17.16%
ROICexgc growth 5Y33.25%
ROICexc growth 3Y-3.08%
ROICexc growth 5Y14.74%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover2.6
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 1.03
Cap/Depr 69.59%
Cap/Sales 1.99%
Interest Coverage 14.26
Cash Conversion 18.86%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.79
F-Score6
WACC6.46%
ROIC/WACC1.05
Cap/Depr(3y)40.77%
Cap/Depr(5y)30.88%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)410.26%
Profit Quality(5y)379.1%
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%
EBIT growth 1Y12.1%
EBIT growth 3Y-4.89%
EBIT growth 5Y21.95%
EBIT Next Year66.67%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-117.59%
FCF growth 3Y-8.31%
FCF growth 5Y-0.45%
OCF growth 1Y-82.03%
OCF growth 3Y1.58%
OCF growth 5Y4.33%

CTAC NV / CTAC.AS FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 7 / 10 and the dividend payout ratio is 26.85%.